Completed PHASE3 INTERVENTIONAL 2-arm NCT00539305

Hormone and Information Processing Study (HIP)

Testosterone Supplementation in Men With MCI

Sponsor: National Institute on Aging (NIA)

Conditions Alzheimer's Disease Mild Cognitive Impairment

Interventions placebo gel testosterone gel

Updated 5 times since 2017 Last updated: Jul 10, 2014 Started: Jul 31, 2009 Primary completion: Jul 31, 2011 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Alzheimer's Disease and Mild Cognitive Impairment, this trial is completed. The trial is conducted by National Institute on Aging (NIA) and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Aging (NIA)
Solvay Pharmaceuticals
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States